Cargando…

Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use

Intravenous and intranasal ketamine have been shown to be effective therapeutic options in patients suffering from treatment-resistant depression (TRD). The use of sublingual (SL), rapid dissolve ketamine tablets (RDT) offers a novel approach for delivery for mental health indications. This study as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassan, Kazi, Struthers, William M., Sankarabhotla, Aditya, Davis, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554222/ https://www.ncbi.nlm.nih.gov/pubmed/36245861 http://dx.doi.org/10.3389/fpsyt.2022.992624

Ejemplares similares

Safety and Tolerability of Intramuscular and Sublingual Ketamine for Psychiatric Treatment in the Roots to Thrive Ketamine Assisted Therapy Program
por: Tsang, V. W. L., et al.
Publicado: (2023)

A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potential
por: Chubbs, Brittany, et al.
Publicado: (2022)

The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study
por: Wallace, Caroline J. K., et al.
Publicado: (2021)

Subcutaneous Ketamine in Depression: A Systematic Review
por: Cavenaghi, Vitor Breseghello, et al.
Publicado: (2021)

Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review
por: Tsang, Vivian W.L., et al.
Publicado: (2023)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
por: Bennett, Raquel, et al.
Publicado: (2022)

Ketamine study: Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation
por: Anzolin, Ana Paula, et al.
Publicado: (2023)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
por: Zheng, Wei, et al.
Publicado: (2022)

Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
por: Zavaliangos-Petropulu, Artemis, et al.
Publicado: (2023)

Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
por: Thai, Michelle, et al.
Publicado: (2020)

Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
por: Zheng, Wei, et al.
Publicado: (2022)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder
por: Willms, Joshua, et al.
Publicado: (2022)

Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review
por: Whinkin, Emily, et al.
Publicado: (2023)

Depression, Estrogens, and Neuroinflammation: A Preclinical Review of Ketamine Treatment for Mood Disorders in Women
por: Gagne, Collin, et al.
Publicado: (2022)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Zheng, Wei, et al.
Publicado: (2021)

A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
por: Zheng, Wei, et al.
Publicado: (2022)

The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
por: Garel, Nicolas, et al.
Publicado: (2023)

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
por: Yip, Ryan, et al.
Publicado: (2022)

Ketamine: Various toxicities following off-label use of ketamine: 3 case reports
Publicado: (2021)

Craving for Ketamine and Its Relationship With Clinical Outcome Indicators in Males With Ketamine Use Disorder
por: Wang, Peng-Wei, et al.
Publicado: (2021)

Home-based transcranial direct current stimulation in dual active treatments for symptoms of depression and anxiety: A case series
por: Sobral, Mónica, et al.
Publicado: (2022)

Meditative Movement for Depression and Anxiety
por: Payne, Peter, et al.
Publicado: (2013)

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
por: Glue, Paul, et al.
Publicado: (2020)

Controversies of the Effect of Ketamine on Cognition
por: Zhang, Melvyn W. B., et al.
Publicado: (2016)

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2021)

Home-administered transcranial direct current stimulation with asynchronous remote supervision in the treatment of depression: feasibility, tolerability, and clinical effectiveness
por: Koutsomitros, Theodoros, et al.
Publicado: (2023)

A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use
por: Fortin, Davide, et al.
Publicado: (2022)

Effectiveness and safety of sublingual misoprostol in medical treatment of the 1st trimester miscarriage: experience of off-label use in Korea
por: Park, Jung Yeon, et al.
Publicado: (2018)

Safety and Tolerability of Both Arm Ischemic Conditioning in Patients With Major Depression: A Proof of Concept Study
por: Wang, Zuowei, et al.
Publicado: (2020)

A Retrospective Naturalistic Study Comparing the Efficacy of Ketamine and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression
por: Mikellides, Georgios, et al.
Publicado: (2022)

Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression
por: Gilbert, Jessica R., et al.
Publicado: (2021)

Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report
por: Elkrief, Laurent, et al.
Publicado: (2022)

Placebo Effect in the Treatment of Depression and Anxiety
por: Kirsch, Irving
Publicado: (2019)

An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
por: Muscat, Sherry-Anne, et al.
Publicado: (2021)

Depressive Symptom Network Associated With Comorbid Anxiety in Late-Life Depression
por: An, Min Ho, et al.
Publicado: (2019)

Editorial: Traditional Chinese medicine for depression and anxiety
por: Yang, Xinjing, et al.
Publicado: (2023)

Cortical Thickness Changes in Chronic Ketamine Users
por: Zhong, Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7epo03csb3nkera4k0tnq7lhen